Rebus (CE) Quote - RBSH

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.000001

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.0126

Market Cap

32.133

Previous Close

0.000001

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

3,973

Shares Outstanding

32,132,907

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0.03

Revenue

Net Profit

-1.02M

Inspyr Therapeutics develops curative cancer therapies that are core to the principles of finding the best way to cure or extend human life. Its innovative approach to drug delivery is expected to maximize anti-tumor activity while minimizing side effects. Inspyr's technology platform combines a pow... Inspyr Therapeutics develops curative cancer therapies that are core to the principles of finding the best way to cure or extend human life. Its innovative approach to drug delivery is expected to maximize anti-tumor activity while minimizing side effects. Inspyr's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of the company's drug candidates within a tumor. Inspyr's lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the blood vessels of liver and glioblastoma cancers and in the blood vessels of almost all other solid tumors. Mipsagargin is expected to have potential efficacy in a wide variety of tumor types. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Camden, Delaware, USA

Founded

Rebus Holdings Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RBSH. The last closing price for Rebus (CE) was US$0. Over the last year, Rebus (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0126.

Rebus (CE) currently has 32,132,907 shares outstanding. The market capitalization of Rebus (CE) is US$32.13 . Rebus (CE) has a price to earnings ratio (PE ratio) of 0.00.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	4072	1.0E-6	CS
12	0	0	1.0E-6	0.0001	1.0E-6	3973	2.869E-5	CS
26	0	0	1.0E-6	0.01	1.0E-6	4171	6.629E-5	CS
52	-0.005899	-99.9830508475	0.0059	0.0126	1.0E-6	139339	0.00254006	CS
156	-0.079999	-99.99875	0.08	0.09995	1.0E-6	267746	0.02223304	CS
260	-0.099899	-99.998998999	0.0999	0.12	1.0E-6	264370	0.02263883	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ISUNQiSun Inc (CE)	US$ 0.0007 (69,900.00%)	19.21k
TTCFQTattooed Chef Inc (CE)	US$ 0.0002 (19,900.00%)	47.92k
HENCHero Technologies Inc (CE)	US$ 0.0001 (9,900.00%)	200k
ECPNEl Capitan Precious Metals Inc (CE)	US$ 0.0001 (9,900.00%)	2.25k
YAYOYayYo Inc (CE)	US$ 0.0001 (9,900.00%)	2.83k
EGBBEarth Gen Biofuel Inc (CE)	US$ 0.000001 (-99.95%)	8k
CNVIFConavi Medical Corporation (PK)	US$ 0.0007 (-99.88%)	1.86k
SCNGSC Holdings Corporation (CE)	US$ 0.000001 (-99.50%)	55k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.000001 (-99.50%)	2.4k
BDPTDBioadaptives Inc	0.081275 (-99.10%)	78.57k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0001 (0.00%)	210.2M
THBDThird Bench Inc (PK)	US$ 0.0003 (200.00%)	112.63M
QEDNQED Connect Inc (PK)	US$ 0.0005 (25.00%)	78.09M
RDARRaadr Inc (PK)	US$ 0.00065 (8.33%)	70.17M
HCMCHealthier Choices Management Corporation (PK)	US$ 0.000001 (0.00%)	69.96M